You searched for lung cancer | Page 7 of 154

New Lung Cancer Classification Model Shows Promise

The first-generation lung cancer classification model based on gene expression data is already available for use within Qlucore Insights.

Posted by Chris Wolski | Apr 18, 2023 | Lung Cancer |

New data demonstrates Exai Bio’s novel RNA- and AI-based platform detected non-small cell lung cancer with high accuracy.

Posted by Andy Lundin | Feb 27, 2023 | Lung Cancer |

The Q-submission phase is a regulatory step which allows regular and in-depth discussions with the FDA on key topics.

Posted by Andy Lundin | Feb 24, 2023 | Lung Cancer |

Lucence announced that Palmetto GBA finalized a foundational local coverage determination (LCD) for the LiquidHALLMARKassay.

Posted by Andy Lundin | Sep 7, 2022 | Lung Cancer |

Implementing lung cancer screening at four diverse healthcare systems resulted in a 6.6% decrease in Stage IV disease.